Clinical trial
Assessment of the Enrichment of Rare Coding Genetic Variants in Patients Affected by Neutrophil-Mediated Inflammatory Dermatoses
NCT01952275 is registered in ClinicalTrials.gov with University of Zurich as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessment of the Enrichment of Rare Coding Genetic Variants in Patients Affected by Neutrophil-Mediated Inflammatory Dermatoses
- Lead sponsor
- University of Zurich
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- January 31, 2014
- Completion date
- January 31, 2020
- Enrollment
- 600 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute generalized exanthematous pustulosis, amicrobial pustulosis of the folds, behcet's disease, bowel-associated dermatosis-arthritis syndrome, bullous systemic lupus erythematosus, dermatitis herpetiformis, erosive pustular dermatosis of the scalp, erythema elevatum diutinum, erythema marginatum, iga pemphigus, infantile acropustulosis, inflammatory epidermolysis bullosa aquisita, keratoderma blenorrhagicum, linear iga bullous dermatosis, medium vessel vasculitis, neutrophilic dermatosis of the dorsal hands (pustular vasculitis), neutrophilic eccrine hidradenitis, neutrophilic urticaria, other specified inflammatory disorders of skin or subcutaneous tissue, pustular psoriasis, pyoderma gangrenosum, rheumatoid neutrophilic dermatitis, small vessel vasculitis including urticarial vasculitis, sneddon-wilkinson disease, still's disease, sweet's syndrome, transient neonatal pustulosis, unclassified periodic fever syndromes / autoinflammatory syndromes